LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 14.58 | 84.90 | 1 | 663 | 0.0015 | -0.7763 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 14.58 | 84.90 | 1062 | 663 | 1.6008 | 1.3438 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 16.29 | 84.90 | 100 | 766 | 0.1304 | 0.0529 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 16.29 | 84.90 | 963 | 766 | 1.2558 | 1.1487 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 16.29 | 84.90 | 2 | 766 | 0.0026 | -0.6929 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 16.29 | 84.90 | 1048 | 766 | 1.3666 | 1.2067 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 17.99 | 84.90 | 146 | 898 | 0.1624 | 0.1726 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 17.99 | 84.90 | 990 | 898 | 1.1013 | 1.0575 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 17.99 | 84.90 | 5 | 898 | 0.0056 | -0.5648 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 17.99 | 84.90 | 1023 | 898 | 1.1380 | 1.0774 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 19.69 | 84.90 | 601 | 1239 | 0.4849 | 0.6587 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 19.69 | 84.90 | 1106 | 1239 | 0.8924 | 0.9420 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 19.69 | 84.90 | 17 | 1239 | 0.0137 | -0.3402 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 19.69 | 84.90 | 1105 | 1239 | 0.8915 | 0.9415 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 21.40 | 84.90 | 608 | 1454 | 0.4180 | 0.6166 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 21.40 | 84.90 | 1049 | 1454 | 0.7211 | 0.8467 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 21.40 | 84.90 | 32 | 1454 | 0.0220 | -0.2118 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 21.40 | 84.90 | 1103 | 1454 | 0.7583 | 0.8694 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 23.10 | 84.90 | 715 | 1616 | 0.4424 | 0.6508 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 23.10 | 84.90 | 1004 | 1616 | 0.6212 | 0.7881 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 23.10 | 84.90 | 57 | 1616 | 0.0353 | -0.0895 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 23.10 | 84.90 | 1047 | 1616 | 0.6478 | 0.8058 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 24.81 | 84.90 | 777 | 1769 | 0.4391 | 0.6575 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 24.81 | 84.90 | 1172 | 1769 | 0.6623 | 0.8205 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 24.81 | 84.90 | 101 | 1769 | 0.0571 | 0.0404 | MN20160318_Q02 | F12 |